Estimaciones de analistas de Wall Street para Aditxt, Inc. (ADTX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Ratios de valoración
| Precio / Valor contable | -0.00 |
| EV / EBITDA | -0.24 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | $105034 | $933715 | $645176 | $133985 | $3195 |
| Coste de Ventas | 0 | 0 | 0 | $17773 | $77979 | $766779 | $756836 | $627474 | $2927 |
| Beneficio Bruto | 0 | 0 | 0 | -$17773 | $27055 | $166936 | -$111660 | -$493000 | $268 |
| I+D | 0 | $525000 | $175441 | $937966 | $5.0M | $7.3M | $7.1M | $10.9M | $3.2M |
| Generales y Administrativos | $212986 | $5.1M | $5.7M | $7.9M | $22.4M | $17.8M | $18.9M | $16.5M | $16.4M |
| Gastos Operativos | $212986 | $5.6M | $5.9M | $8.9M | $42.0M | $25.6M | $26.0M | $27.4M | $19.6M |
| Beneficio Operativo | -$213000 | -$5.6M | -$5.9M | -$8.9M | -$41.9M | -$25.5M | -$26.1M | -$27.9M | -$19.6M |
| EBITDA | $638958 | 0 | $45000 | -$8.8M | -$44.0M | -$24.8M | -$25.5M | -$27.0M | -$40.1M |
| Gastos por Intereses | 0 | $79766 | $1930 | $310081 | $1.9M | $2.3M | $6.4M | $7.4M | $2.4M |
| Beneficio Antes de Impuestos | -$852000 | -$5.7M | -$5.8M | -$9.1M | -$46.4M | -$27.6M | -$32.4M | -$35.0M | -$42.8M |
| Impuestos | -$852000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$213000 | -$5.7M | -$5.8M | -$9.1M | -$46.4M | -$27.6M | -$32.4M | -$34.4M | -$41.7M |
| BPA | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-3062.42 | $-1153.83 |
| BPA Diluido | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-3062.42 | $-1153.83 |
| Acciones en Circulación (Diluidas) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $13177 | $37355 |
Precio
| Precio | $0.01 |
| Capitalización | $5M |
| Bolsa | OTC |
| País | US |
Empresas relacionadas: AIMD · ANL · APLM · ATHA · BLRX · CTXR · GOVX
Explorar sector: Healthcare · Biotechnology
Más secciones de ADTX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones